Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
US10479793B2 · kind B2 · utility
1Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2016 |
| Grant date | Nov 19, 2019 |
| Priority date | — |
| Expiry date | Nov 17, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula I or a stereoisomer or pharmaceutically-acceptable salt thereof, are useful in the modulation of IL-12, IL-23 and/or IFNα, by acting on Tyk-2 to cause signal transduction inhibition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.